Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Talcott

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Practical Radiation Oncology|September 5, 2020
A Blinded, Prospective Study of Error Detection During Physician Chart Rounds in Radiation OncologyWesley J Talcott, Holly Lincoln, Jacqueline R Kelly, et al.
Prostate Cancer and Prostatic Diseases|September 29, 2020
Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patientsJoseph A Miccio, Wesley J Talcott, Vikram Jairam, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situWesley J Talcott, Joseph A Miccio, Henry S Park, et al.
Clinical and Translational Radiation Oncology|January 4, 2021
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisJoseph A Miccio, Wesley J Talcott, Timil Patel, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Practical Radiation Oncology|September 5, 2020
A Blinded, Prospective Study of Error Detection During Physician Chart Rounds in Radiation OncologyWesley J Talcott, Holly Lincoln, Jacqueline R Kelly, et al.
Prostate Cancer and Prostatic Diseases|September 29, 2020
Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patientsJoseph A Miccio, Wesley J Talcott, Vikram Jairam, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2021
Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situWesley J Talcott, Joseph A Miccio, Henry S Park, et al.
Clinical and Translational Radiation Oncology|January 4, 2021
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisJoseph A Miccio, Wesley J Talcott, Timil Patel, et al.
Pageof 3